2024 Annual Shareholders' Meeting Results

News Release STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH) 2024 Annual Shareholders’ Meeting Results Auckland, New Zealand, 28 August 2024 – Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed. The five resolutions were: Resolution 1: To re-elect Sir Michael Daniell as a Director. Resolution 2: To elect Graham McLean as a Director. Resolution 3: To authorise the Directors to fix the fees and expenses of the company’s auditor. Resolution 4: To approve the issue of performance share rights to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2024. Resolution 5: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2024. All resolutions were decided by poll. The details of the total number of votes cast online, in person or by proxy on the polls were as follows: Resolution Votes: Resolution 1: Re-election of Sir Michael Daniell For: 423,197,532 (94.36%); Against: 25,288,101 (5.64%); Abstain: 44,380 Resolution 2: Election of Graham McLean as a Director For: 364,226,483 (81.22%); Against: 84,241,690 (18.78%); Abstain: 61,840 Resolution 3: Approval of auditor fees and expenses For: 443,551,242 (98.90%); Against: 4,945,161 (1.10%); Abstain: 33,610 Resolution 4: Issue of performance share rights to Lewis Gradon For: 437,611,155 (97.82%); Against: 9,759,397 (2.18%); Abstain: 581,072 Resolution 5: Issue of options to Lewis Gradon For: 437,547,884 (97.78%); Against: 9,939,083 (2.22%); Abstain: 464,657 About Fisher & Paykel Healthcare Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com. Contacts Media Karen Knott GM Corporate Communications karen.knott@fphcare.co.nz +64 (0) 21 713 911 Investors Dan Adolph Head of Investor Relations daniel.adolph@fphcare.co.nz +64 (0) 22 511 4050 Authorised by Raelene Leonard, General Counsel & Company Secretary.